Document is current
Any future updates will be listed below
-
Authors
Hugerth, Luisa W.
Krog, Maria Christine
Vomstein, Kilian
Du, Juan
Bashir, Zahra
Kaldhusdal, Vilde
Fransson, Emma
Engstrand, Lars
Nielsen, Henriette Svarre
Schuppe-Koistinen, Ina
-
Funding
Funding for this research was provided by:
Science for Life Laboratory (KAW 2020.0239)
Ferring Pharmaceuticals
Rigshospitalet (E-22614-01, E-22614-02)
Vetenskapsrådet (2021-01683)
Copenhagen University
- License Information
-
More Information
Article History
Received: 6 June 2023
Accepted: 9 July 2024
First Online: 19 August 2024
Declarations
:
: The study is approved by The Regional Ethics Committee on Health Research (H-17017580) and the Data Protection Agency in the Capital Region of Denmark (2012–58-0004). All data were collected and hosted using REDCap electronic data capture tools [] hosted by the Capital Region of Denmark.
: All participants gave oral and written consent to participate according to the Helsinki Declaration and were remunerated with 3,000 DKK after completing sample collection.
: The Centre for Translational Microbiome Research is partly funded by Ferring Pharmaceuticals (LWH, EF, JD, LE, IS-K). An unrestricted research grant from Ferring Pharmaceuticals enabled the clinical infrastructure and sampling (MCK, ZB and HSN). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
